Clinical Pharmacology Units (CPUs)
Phase I-II Clinical Trials. Inpatient or Outpatient. Our CPUs and research centers yield success.
Phase I-II Clinical Research Sites
WCCT owns, operates, and partners with multiple clinical sites throughout the Southern California region:
- One Phase I unit certified as an American Heart Association training site
- On-site CLIA-certified Safety Reference Laboratory
- Peripheral Blood Mononuclear Cell (PBMC) processing capabilities
- One Phase I-II clinical research site distinguished as the first approved U.S. commercial facility capable of conducting influenza challenge studies
Because we also manage studies at the CRO level, our clinical pharmacology units have top-down insight into the clinical process that has been further operationalized through the use of our electronic data capture tools to produce a more comprehensive level of data for our sponsors. Unlike most sites, ours have the business support needed to meet all goals in timelines, budget, recruitment and retention. Our unique approach to clinical study management yields success.
Clinical Research Sites and Pharmacology Units
Strategically situated to recruit from large, diverse ethnic populations, WCCT’s clinical trial sites and clinical pharmacology units (CPUs) can not only meet your recruitment and retention goals, but they have the administrative support needed to meet your timelines and operate within your budget.
WCCT’s Phase I CPU and largest location. Overnight accommodations for up to 180 volunteers. Multilingual call center for subject recruitment. Houses a Safety Reference Laboratory.
Learn More
With 30 rooms, this special-population studies CPU can house up to 60 subjects and can house influenza challenge studies.
Learn More
Early Clinical Development
Blog
The blog delivers industry-related developments and announcements regarding expanded clinical services.